Yep, the addressable population in Pitt Hopkins is smaller than Phelan-McDermid, but the effect of having 2 successful trials with the same drug more than makes up for that imo.
I don't know about others here, but I got enough on the line here to be nervous. Confident, but definately buzzing.
Good luck everyone.
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-10265
-
-
- There are more pages in this discussion • 454 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.98 |
Change
-0.020(0.10%) |
Mkt cap ! $2.553B |
Open | High | Low | Value | Volume |
$20.05 | $20.28 | $19.82 | $5.032M | 251.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 364 | $19.96 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.98 | 292 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 20.600 |
1 | 1 | 20.500 |
1 | 19 | 20.450 |
1 | 931 | 20.200 |
1 | 3 | 20.010 |
Price($) | Vol. | No. |
---|---|---|
17.990 | 760 | 7 |
19.000 | 1411 | 3 |
19.400 | 175 | 1 |
19.410 | 7 | 1 |
19.500 | 971 | 1 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |